Results 251 to 260 of about 9,616,743 (356)

Anchorage‐independent and faster growth in clonal population from UV‐irradiated NER‐deficient cells

FEBS Open Bio, EarlyView.
UV‐irradiated cells expressing a DDB2 mutant protein unable to interact with PCNA (DDB2PCNA‐) form clones able to grow without anchorage. Different experimental approaches reveal heterogeneity in cell cycle regulation and drug response within these clones, emphasizing the crucial role of the DDB2‐PCNA interaction in preventing cellular transformation ...
Paola Perucca, Anna Tricarico, Martina Furfaro, Priyam Ghosh, Ennio Prosperi, Lucia Anna Stivala, Ornella Cazzalini   +6 more
wiley   +1 more source

Evaluating Rational Drug Use in Developing Countries: A Cross-Sectional Analysis of Prescribing Patterns Against WHO Indicators in Pakistan and Yemen. [PDF]

Pharmacol Res Perspect
Khan A, Al-Subari AMA, Mushtaq S, Hameed K, Abbas S, Iqbal M, Dong Y, Feng W, Fang Y.   +8 more
europepmc   +1 more source

Report drawn up on behalf of the Committee on the Environment, Public Health and Consumer Protection on the export of pharmaceutical products from the European Community to the countries of the third world. Working Documents 1986-1987, Document A2-36/86, 12 May 1986 [PDF]

, 1986
Banotti, Mary
core  

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines

FEBS Open Bio, EarlyView.
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart, Manon Van den Abbeel, Christoph Schifflers, Karim Bouhjar, Andrea Scarmelotto, Alexis Khelfi, Anne‐Catherine Wera, Carine Michiels   +7 more
wiley   +1 more source

Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials. [PDF]

Int J Nanomedicine
Su G, Xu W.
europepmc   +1 more source

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

Cancer: a looming public health crisis in Africa-a call to accelerate equitable access to medicines. [PDF]

Oncologist
Anorlu RI, Amaeshi LC, Okunade KS, Okunowo AA, Ohazurike EO, Soibi Harry AP, Duru ON, Murphy A.   +7 more
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

Prescribing Patterns and Medication Appropriateness in General Medicine: Evaluation of Adherence to WHO Guidelines at a Tertiary Care Teaching Hospital in South Delhi, India. [PDF]

Cureus
Khanna S, Zee Fahem A, Malik B, Malik M.
europepmc   +1 more source

Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. [PDF]

, 2004
Berman, D, Calmy, A, Ferradini, L, Klement, E, Pécoul, B, Teck, R   +5 more
core   +1 more source